
---
title: '吓懵，3000亿巨头逼近跌停！户均亏损14万，这则消息或成_元凶_。业绩增速下滑且大比例拟减持股来了，最高减持9%'
categories: 
 - 金融
 - 证券时报网
 - 数据
headimg: 'https://data.stcn.com/djsj/202206/W020220613457046486162.jpeg'
author: 证券时报网
comments: false
date: Mon, 13 Jun 2022 12:40:00 GMT
thumbnail: 'https://data.stcn.com/djsj/202206/W020220613457046486162.jpeg'
---

<div>   
<p style="text-align: left;">80余股发布减持计划后跌停，分析人士认为未来有减持计划且业绩相对一般的股票值得警惕。</p><p style="text-align: left;"><strong>20万股东“哭了”，3000亿CRO龙头早盘一度跌停</strong></p><p style="text-align: left;">上周五，美股暴跌，或受此影响，6月13日早盘，A股小幅低开，板块表现冰火两重天，在为数不多的大幅下跌股中，出现了<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603259" code="603259">药明康德</a>身影。</p><p style="text-align: left;"><a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603259" code="603259">药明康德</a>A、H股盘中均一度大跌超过9%，其A股一度跌停；公司早盘一直在跌停线徘徊，截至早盘收盘，其A股股价大幅下跌9.51%，H股下跌10.29%。</p><p style="text-align:center"><img class="rich_pages wxw-img" data-ratio="1.2324074" src="https://data.stcn.com/djsj/202206/W020220613457046486162.jpeg" data-type="jpeg" data-w="1080" data-imgqrcoded="1" style="margin: 0px; padding: 0px; max-width: 100%; vertical-align: middle; box-sizing: border-box; height: 616.204px; overflow-wrap: break-word !important; width: 500px;" width="500px" height="616.2037037037037px" oldsrc="W020220613457046486162.jpeg" referrerpolicy="no-referrer"></p><p style="text-align: left;">截至最新收盘日，全球领先的"一体化、端到端"的新药研发服务平台公司<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603259" code="603259">药明康德</a>总市值超过3000亿，今日早盘市值蒸发289.1亿元，按照一季末的20.66万户股东计算，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603259" code="603259">药明康德</a>股东户均亏损近14万元。</p><p style="text-align: left;"><a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603259" code="603259">药明康德</a>自上市以来，跌停极为少见。证券时报·数据宝统计，A股公司于2021年12月15日、2022年2月8日呈跌停状态。本次跌停或与这则减持计划有直接关系。</p><p style="text-align: left;">6月10日盘后，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603259" code="603259">药明康德</a>发布公告称，因自身资金需求，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603259" code="603259">药明康德</a>实际控制人控制的股东及与实际控制人签署一致行动协议的股东，根据市场情况自本公告之日起15个交易日后的不超过90日期间内合计减持不超过公司总股本3%的A股股份。其中，通过集中竞价方式合计减持不超过公司总股本的1%，通过大宗交易方式合计减持不超过公司总股本的2%。以<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603259" code="603259">药明康德</a>上周五收盘市值计算，上述减持市值最高将达91.2亿元。</p><p style="text-align:center"><img class="rich_pages wxw-img" data-ratio="1.0337458" src="https://data.stcn.com/djsj/202206/W020220613457050020919.png" data-type="png" data-w="889" data-imgqrcoded="1" style="margin: 0px; padding: 0px; max-width: 100%; vertical-align: middle; box-sizing: border-box; box-shadow: rgb(180, 180, 180) 0em 0em 0.5em 0px; height: 516.873px; overflow-wrap: break-word !important; width: 500px;" width="500px" height="516.872890888639px" oldsrc="W020220613457050020919.png" referrerpolicy="no-referrer"></p><p style="text-align: left;">值得一提的是，公司股权激励限售股份于7月1日即将解禁，预计617.1万股符合解禁条件，与减持计划的起始时间仅隔1个交易日。</p><p style="text-align: left;"><strong>CRO概念股跌幅垫底，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603259" code="603259">药明康德</a>遭机构砸盘</strong></p><p style="text-align: left;">据悉，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603259" code="603259">药明康德</a>是国际领先的开放式能力与技术平台，即CRO龙头。受<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603259" code="603259">药明康德</a>拖累，今日早盘，CRO概念股跌幅垫底，跌幅仅次于租售同权板块。板块内<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300149" code="300149">睿智医药</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603127" code="603127">昭衍新药</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS688202" code="688202">美迪西</a>等公司跌幅超过5%。</p><p style="text-align: left;">数据宝统计，机构资金大幅流出。截至早盘收盘，CRO板块机构资金净流出近6亿元，机构资金净流出7股。仅<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603259" code="603259">药明康德</a>1家公司的净流出额就超过了5亿，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002821" code="002821">凯莱英</a>净流出额超过7000万元，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603456" code="603456">九洲药业</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300347" code="300347">泰格医药</a>净流出超过500万元。</p><p style="text-align:center"><img class="rich_pages wxw-img" data-ratio="0.5014164" src="https://data.stcn.com/djsj/202206/W020220613457051299045.png" data-type="png" data-w="706" data-imgqrcoded="1" style="margin: 0px; padding: 0px; max-width: 100%; vertical-align: middle; box-sizing: border-box; height: 250.708px; overflow-wrap: break-word !important; width: 500px;" width="500px" height="250.7082152974504px" oldsrc="W020220613457051299045.png" referrerpolicy="no-referrer"></p><p style="text-align: left;"><strong>80余股发布减持计划后跌停，千亿市值股仅3只</strong></p><p style="text-align: left;">事实上，在A股历史上发布减持计划后跌停的情形不在少数。证券时报·数据宝统计，以2020年以来的减持计划来看，按照首次公告日来计算，发布减持计划次日，相关公司平均下跌近1%，下跌股数量相对较多。</p><p style="text-align: left;">发布次日跌停股有80余只，如<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300111" code="300111">向日葵</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300712" code="300712">永福股份</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300677" code="300677">英科医疗</a>等，但跌停前市值超千亿股仅有3只，分别是<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600111" code="600111">北方稀土</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ000625" code="000625">长安汽车</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603260" code="603260">合盛硅业</a>，可见跌停股主要以中小市值股为主。</p><p style="text-align: left;">也有少数公司发布减持计划次日呈涨停，如<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300549" code="300549">优德精密</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300264" code="300264">佳创视讯</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300619" code="300619">金银河</a>等。</p><p style="text-align: left;">将时间拉长看，首次公告以来截至最新收盘日，上述减持计划股平均跌幅超过3.5%，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ000710" code="000710">贝瑞基因</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002912" code="002912">中新赛克</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603160" code="603160">汇顶科技</a>期间跌幅均超过75%。</p><p style="text-align:center"><img class="rich_pages wxw-img" data-ratio="0.9366106" src="https://data.stcn.com/djsj/202206/W020220613457052901896.png" data-type="png" data-w="773" data-imgqrcoded="1" style="margin: 0px; padding: 0px; max-width: 100%; vertical-align: middle; box-sizing: border-box; height: 468.305px; overflow-wrap: break-word !important; width: 500px;" width="500px" height="468.3053040103493px" oldsrc="W020220613457052901896.png" referrerpolicy="no-referrer"></p><p style="text-align: left;"><strong>21只业绩增速下滑股拟减持比例上限超过3%</strong></p><p style="text-align: left;">在对<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603259" code="603259">药明康德</a>进一步研究中发现，公司今年一季度净利润同比增速不到10%，较2021年同期大幅下滑。国金、中泰等机构认为其二季度、全年业绩预期不变，有望延续高增长，但投资者似乎仍不买账，毕竟医药板块整体依然处于下行阶段。对此，分析人士认为未来有减持计划且业绩相对一般的股票值得警惕。</p><p style="text-align: left;">数据宝统计，6月以来发布减持计划的151股中，2022年一季度净利润增速下滑股多达110家，其中拟减持比例上限超过的有21股，居前的有<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS688579" code="688579">山大地纬</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300906" code="300906">日月明</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300459" code="300459">汤姆猫</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300815" code="300815">玉禾田</a>等，前2股拟减持比例上限超过6%。其中<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS688579" code="688579">山大地纬</a>2021年一季度净利润同比增长49.36%，今年一季度净利润同比下滑18.92%。</p><p style="text-align: left;">从业绩增速来看，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300877" code="300877">金春股份</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603598" code="603598">引力传媒</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300701" code="300701">森霸传感</a>等4股2022年一季度净利润同比下滑超过50%，去年同期这些公司业绩均呈增长状态。</p><p style="text-align: left;">市场表现看，首次公告以来，特力A、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603139" code="603139">康惠制药</a>等累计上涨超过3%；<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300906" code="300906">日月明</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ000718" code="000718">苏宁环球</a>等跌幅超过4%。（数据宝 张娟娟）</p><p style="text-align:center"><img class="rich_pages wxw-img" data-ratio="0.8608894" src="https://data.stcn.com/djsj/202206/W020220613457056983968.png" data-type="png" data-w="877" data-imgqrcoded="1" style="margin: 0px; padding: 0px; max-width: 100%; vertical-align: middle; box-sizing: border-box; height: 430.445px; overflow-wrap: break-word !important; width: 500px;" width="500px" height="430.4446978335233px" oldsrc="W020220613457056983968.png" referrerpolicy="no-referrer"></p><p style="text-align: left;">声明：数据宝所有资讯内容不构成投资建议，股市有风险，投资需谨慎。</p>
  
</div>
            